Assyro AI

FDA Orange Book · active-ingredient family

Bethanechol chloride

Bethanechol chloride is approved as 1 brand and 52 generic applications in the FDA Orange Book, with their therapeutic-equivalence codes, listed patents, and marketing exclusivity.

Reference-listed drug:URECHOLINE · NDA 006536

1

Brand (NDA)

52

Generics (ANDA)

0

Listed patents

0

Exclusivity periods

Brand (NDA) products · injectable, tablet

ProductApplicantApplicationTEApproved
URECHOLINERLD×5TEVA BRANDED PHARMNDA 006536Approved Prior to Jan 1, 1982

Generic (ANDA) products (52)

ProductApplicantApplicationTEApproved
BETHANECHOL CHLORIDE×4HERITAGE PHARMAANDA 091256AAMay 04, 2010
BETHANECHOL CHLORIDE×4SUN PHARM INDS INCANDA 040897Apr 22, 2009
BETHANECHOL CHLORIDE×4LANNETT CO INCANDA 040677Mar 27, 2008
BETHANECHOL CHLORIDE×4AMNEAL PHARMANDA 040855AANov 21, 2007
BETHANECHOL CHLORIDE×4CHARTWELL RXANDA 040728AAOct 26, 2007
BETHANECHOL CHLORIDE×4IMPAX LABSANDA 040721Nov 01, 2006
BETHANECHOL CHLORIDEUPSHER SMITH LABSANDA 040633AAJun 01, 2005
BETHANECHOL CHLORIDEUPSHER SMITH LABSANDA 040634AAJun 01, 2005
BETHANECHOL CHLORIDEUPSHER SMITH LABSANDA 040635AAJun 01, 2005
BETHANECHOL CHLORIDEUPSHER SMITH LABSANDA 040636AAJun 01, 2005
BETHANECHOL CHLORIDEACTAVIS ELIZABETHANDA 040552Oct 28, 2004
BETHANECHOL CHLORIDEACTAVIS ELIZABETHANDA 040553Oct 28, 2004
BETHANECHOL CHLORIDEACTAVIS ELIZABETHANDA 040554Oct 28, 2004
BETHANECHOL CHLORIDEACTAVIS ELIZABETHANDA 040551Oct 28, 2004
BETHANECHOL CHLORIDEABLEANDA 040492Jul 27, 2004
BETHANECHOL CHLORIDEABLEANDA 040483Jul 27, 2004
BETHANECHOL CHLORIDEABLEANDA 040485Jul 27, 2004
BETHANECHOL CHLORIDEABLEANDA 040509Jul 27, 2004
BETHANECHOL CHLORIDEWOCKHARDTANDA 040532Sep 29, 2003
BETHANECHOL CHLORIDEWOCKHARDTANDA 040533Sep 29, 2003
BETHANECHOL CHLORIDEWOCKHARDTANDA 040534Sep 29, 2003
BETHANECHOL CHLORIDEWOCKHARDTANDA 040518Sep 29, 2003
URECHOLINEODYSSEY PHARMSANDA 089095Dec 19, 1985
URECHOLINEODYSSEY PHARMSANDA 089096Dec 19, 1985
URECHOLINERLDODYSSEY PHARMSANDA 088440May 29, 1984
URECHOLINERLDODYSSEY PHARMSANDA 088441May 29, 1984
BETHANECHOL CHLORIDEASCOTANDA 088288Jun 08, 1983
BETHANECHOL CHLORIDEASCOTANDA 088289Jun 08, 1983
BETHANECHOL CHLORIDEIVAX SUB TEVA PHARMSANDA 084689Approved Prior to Jan 1, 1982
BETHANECHOL CHLORIDELANNETTANDA 084702Approved Prior to Jan 1, 1982
BETHANECHOL CHLORIDELANNETTANDA 084712Approved Prior to Jan 1, 1982
BETHANECHOL CHLORIDELANNETTANDA 084074Approved Prior to Jan 1, 1982
BETHANECHOL CHLORIDESANDOZANDA 084353Approved Prior to Jan 1, 1982
BETHANECHOL CHLORIDESANDOZANDA 084378Approved Prior to Jan 1, 1982
BETHANECHOL CHLORIDESANDOZANDA 084379Approved Prior to Jan 1, 1982
BETHANECHOL CHLORIDESANDOZANDA 084383Approved Prior to Jan 1, 1982
BETHANECHOL CHLORIDESANDOZANDA 084384Approved Prior to Jan 1, 1982
BETHANECHOL CHLORIDEWATSON LABSANDA 084402Approved Prior to Jan 1, 1982
BETHANECHOL CHLORIDEWATSON LABSANDA 085230Approved Prior to Jan 1, 1982
BETHANECHOL CHLORIDEWATSON LABSANDA 085841Approved Prior to Jan 1, 1982
BETHANECHOL CHLORIDEWATSON LABSANDA 084408Approved Prior to Jan 1, 1982
BETHANECHOL CHLORIDEWATSON LABSANDA 085228Approved Prior to Jan 1, 1982
BETHANECHOL CHLORIDEWATSON LABSANDA 085842Approved Prior to Jan 1, 1982
BETHANECHOL CHLORIDEWATSON LABSANDA 084441Approved Prior to Jan 1, 1982
BETHANECHOL CHLORIDEWATSON LABSANDA 085229Approved Prior to Jan 1, 1982
BETHANECHOL CHLORIDEWATSON LABSANDA 085839Approved Prior to Jan 1, 1982
BETHANECHOL CHLORIDEWATSON LABSANDA 087397Approved Prior to Jan 1, 1982
BETHANECHOL CHLORIDEWATSON LABSANDA 087444Approved Prior to Jan 1, 1982
DUVOIDCHARTWELL RXANDA 086262AAApproved Prior to Jan 1, 1982
DUVOIDCHARTWELL RXANDA 086263AAApproved Prior to Jan 1, 1982
DUVOIDCHARTWELL RXANDA 085882AAApproved Prior to Jan 1, 1982
MYOTONACHOL×3GLENWOODANDA 084188Approved Prior to Jan 1, 1982

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Bethanechol chloride — frequently asked questions

Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.